Skip to main content
. Author manuscript; available in PMC: 2011 Aug 9.
Published in final edited form as: Antivir Ther. 2011;16(5):667–675. doi: 10.3851/IMP1815

Figure 2. Cumulative probability of liver-related death or development of cirrhosis according to randomization group and baseline hyaluronic acid (HA) (ng/mL) level in coinfected participants.

Figure 2

DC: drug conservation, VS: viral suppression

Log rank test: p<0.0001 (overall), p<0.0001 (DC + HA >75 ng/mL vs. 3 other groups), p=0.20 (3 groups other than DC + >HA 75 ng/mL)